Kyntra Bio amends revenue interest deal with Project Phoebus
Kyntra Bio amended its revenue interest deal with NQ Project Phoebus, cutting the cap to $65M and paying $42.6M.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Kyntra Bio amended its revenue interest deal with NQ Project Phoebus, cutting the cap to $65M and paying $42.6M.